MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Exelixis ROE Ratio 2011-2025 | EXEL
Annual ROE Ratio Exelixis
| 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.23 | 9.18 | 7.33 | 10.45 | 19.04 | 19.04 | 53.6 | 54.12 | 162.73 | 162.73 | 233.86 | -369.52 | -49.81 | 83.55 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 233.86 | -369.52 | 29.97 |
Quarterly ROE Ratio Exelixis
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.72 | 26.95 | 28.53 | 17.61 | 17.65 | 12.51 | 5.05 | 4.82 | 7.76 | 10.65 | 10.4 | 8.88 | 10.17 | 9.04 | 10.79 | 7.88 | 10.67 | 7.13 | 6.08 | 8.77 | 10.77 | 18.58 | 20.24 | 16.86 | 44.83 | 52.57 | 54.06 | 57.59 | 43.13 | 57.86 | 57.26 | 54.12 | 79.94 | 16.14 | -29.06 | -101.22 | -111.03 | 39.08 | 117.77 | 215.95 | 222.8 | 162.41 | 186.66 | 219.77 | -304.58 | -460.4 | -618.17 | -750.68 | -284.63 | -194.36 | -112.82 | -54.12 | 18.88 | 115.87 | 105.03 | 83.52 | 85.91 | -23.14 | -30.33 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 222.8 | -750.68 | -11.27 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Arbutus Biopharma Corporation
ABUS
|
-68.71 | $ 4.9 | 4.03 % | $ 813 M |  Canada |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Aclaris Therapeutics
ACRS
|
-84.9 | $ 3.21 | -1.38 % | $ 248 M |  USA |
 |
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | USA |
 |
Aptevo Therapeutics
APVO
|
-507.47 | $ 1.06 | -6.22 % | $ 293 K | USA |
 |
Catalyst Biosciences
CBIO
|
540.06 | $ 13.33 | -5.39 % | $ 878 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
-43.41 | $ 214.55 | -2.66 % | $ 5 B |  Danmark |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.1 | -5.93 % | $ 7.46 B |  Australia |
 |
Celldex Therapeutics
CLDX
|
-21.13 | $ 27.09 | -1.53 % | $ 1.74 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
20.78 | $ 88.51 | 0.59 % | $ 9.14 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
22.52 | $ 24.35 | 3.07 % | $ 2.88 B | USA |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
CureVac N.V.
CVAC
|
-59.8 | $ 5.02 | -0.59 % | $ 934 M | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
BioVie
BIVI
|
-92.27 | $ 1.43 | -1.72 % | $ 2.11 M | USA |
 |
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-288.19 | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
1.11 | $ 93.99 | -0.86 % | $ 27.2 B | Germany |
 |
Aeglea BioTherapeutics
AGLE
|
-40.17 | - | - | $ 1.01 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
4.58 | $ 10.88 | 0.74 % | $ 1.41 B | USA |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
21.78 | $ 26.44 | 4.63 % | $ 1.28 B | USA |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Anika Therapeutics
ANIK
|
-38.95 | $ 9.6 | 0.42 % | $ 141 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-6.05 | $ 15.97 | -4.37 % | $ 410 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 0.26 | -6.9 % | $ 566 M |  Israel |
 |
Evogene Ltd.
EVGN
|
-41.09 | $ 1.04 | -3.7 % | $ 27.9 M | Israel |
 |
Arena Pharmaceuticals
ARNA
|
-91.56 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-531.22 | - | 3.77 % | $ 22.4 M | USA |
 |
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | USA |
 |
Avenue Therapeutics
ATXI
|
-418.16 | - | -52.27 % | $ 4.45 M | USA |
|
Foghorn Therapeutics
FHTX
|
190.26 | $ 4.39 | -1.13 % | $ 241 M | USA |
 |
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | USA |
 |
Axon Enterprise
AXON
|
16.2 | $ 551.37 | -2.29 % | $ 41.8 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-71.51 | $ 2.35 | 2.17 % | $ 14.8 M | USA |
 |
AstraZeneca PLC
AZN
|
20.44 | $ 91.19 | 1.51 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
10.1 | $ 8.88 | -1.33 % | $ 1.45 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
-19.35 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
114.5 | $ 11.25 | -2.43 % | $ 728 M | USA |
 |
Biogen
BIIB
|
9.76 | $ 174.69 | 0.34 % | $ 25.4 B | USA |